Clinical Trial Update: Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating Laser-Assisted Immunotherapy (LIT/inCVAX) in advanced breast cancer was terminated; no further results reported in the provi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Laser-Assisted Immunotherapy (LIT/inCVAX)

Snippet

Sponsor: Eske Corporation S.A.C | Conditions: Breast Cancer Stage IIIA, Breast Cancer, Stage IIIB | Phase 3 | Status: TERMINATED